Goerlich Pharma
Goerlich Pharma is a German B2B contract manufacturer of food supplements and foods for medical purposes, founded in 1984 and based in Edling, Bavaria. It produces private-label and ready-to-market products across seven galenic dosage forms — including capsules, tablets, sticks, oils, and powder — for supplement brands and retailers.
- Company typePrivate
- Founded1984
- HeadquartersNolle, Germany
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Goerlich Pharma does
Goerlich Pharma GmbH is a German B2B contract manufacturer of food supplements and foods for medical purposes, headquartered in Edling, Bavaria (Munich metropolitan region), operating continuously since 1984 with 51-100 employees. The company manufactures private-label and ready-to-market products across seven galenic dosage forms — hard capsules, soft capsules, tablets, sticks and sachets, oil mixtures, coating/filming, and powder — for food supplement brands, retailers with private-label programs, and market entrants seeking rapid product launch. Service scope spans the full value chain from product ideation and sourcing through certified production and packaging, including blisters, folding boxes, containers/jars, and liquid and stick filling.
Core technology centers on gentle, thermally sensitive processing: molecular (short-path) distillation operating between 1 and 0.001 mbar for omega-3 and similar heat-sensitive actives, enzymatic re-esterification to convert ethyl esters back to triglyceride form for improved bioavailability, and specialized multi-strain probiotic manufacturing capabilities. The company holds an exclusive DACH-region partnership with Epax Norway AS for premium marine omega-3 concentrates (EPAX 1050 TG, EPAX 4020 TG, TGN), and offers a parallel vegan algae-oil (Schizochytrium sp.) line for plant-based formulations. Quality infrastructure is anchored by ISO 9001:2015, ISO 22000:2018, BIO (DE-ÖKO 005), Friend of the Sea, and Marine Stewardship Council certifications.
Revenue is generated through contract manufacturing fees, development services, and private-label/ready-to-market product sales, with quote-based pricing distributed via direct B2B sales, a customer login portal, and partner referrals. The company does not disclose revenue publicly and operates as a privately held GmbH with no disclosed PE or VC backing. Customer segments are horizontal B2B food supplement brands and market entrants, served through an enterprise field-sales motion anchored by named project managers and a centralized sales contact ([email protected]). Strategic positioning emphasizes end-to-end service, German manufacturing heritage, multi-certification compliance, and category breadth across 13 health-focused product worlds including eye health, women's health, longevity, and sport/fitness.
Goerlich Pharma firmographics
Firmographics- Name
- Goerlich Pharma
- Legal name
- Goerlich Pharma GmbH
- Website
- https://goerlich-pharma.com
- Company type
- Private
- Founded year
- 1984
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Goerlich Pharma is a German B2B contract manufacturer of food supplements and foods for medical purposes, founded in 1984 and based in Edling, Bavaria. It produces private-label and ready-to-market products across seven galenic dosage forms — including capsules, tablets, sticks, oils, and powder — for supplement brands and retailers.
- Ownership category
- akta.pro rank
Goerlich Pharma industry classification
Industry- Product category
- Contract Manufacturing - Dietary Supplements
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Food And Kindred Products (2000)
- akta.pro primary industry
- Functional Foods & Supplement Formats (Gummies, Chews, Powders, Shots) (CRADAGAI)
- akta.pro secondary industries
- Probiotics & Digestive Health Supplements (CRADAGAF), Women’s Health Supplements (Prenatal, Menopause, Hormonal) (CRADAGAK), Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE)
Keywords
Where Goerlich Pharma is headquartered
LocationHeadquarters
- HQ city
- Nolle
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Goerlich Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Contract Manufacturing Services: Full-service contract manufacturing for food supplements including product development, sourcing, production, and packaging. Services cover the entire value chain from product idea to market-ready delivery. Revenue generated through manufacturing fees, development services, and production contracts for private label customers.
- Private Label Products: Sale of ready-to-market and private label food supplement products in various galenic forms (capsules, tablets, sticks, oils). Products are manufactured under customer brands with flexible formulations.
- Ready-to-Market Products: Pre-formulated product catalog available for rapid market entry, including basic formulations with omega-3, probiotics, and other ingredients that can be quickly branded and launched.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Goerlich Pharma product offering
Product offeringCore offering
Goerlich Pharma is a German B2B contract manufacturer and packager of food supplements and foods for medical purposes, offering full-service support from product idea to market-ready delivery. The company produces seven galenic dosage forms (hard capsules, soft capsules, tablets, sticks & sachets, oil mixtures, coating/filming, and powder) and supplies both custom private label and ready-to-market formulations across health categories including omega-3, probiotics, eye health, cardiovascular, immune system, women's health, beauty, longevity, and sport & fitness.
Product overview
Goerlich Pharma is a German contract manufacturer of food supplements offering a comprehensive portfolio of galenic dosage forms (hard capsules, soft capsules, tablets, sticks & sachets, oil mixtures, coating/filming, and powder) combined with ready-to-market private label products and specialized product lines. The core offering spans seven galenic forms manufactured at their Munich metropolitan region facility, supplemented by proprietary sub-brands including Epax Omega-3 premium marine concentrates, vegan algae oil products (Omega-3 Vegan Daily, Forte, and Meno variants), probiotic formulations (Probiotic Purple Natural), and comprehensive packaging services (blisters, folding boxes, containers, liquid and stick filling). Products are organized into 13 health-focused product worlds covering eye health, brain & psyche, cardiovascular, immune system, women's health, beauty from inside, longevity, sport & fitness, and other health categories. The company serves as both a B2B contract manufacturer and private label product provider.
Differentiator
Problem solved
Functional benefit
Products and services
- Full-Service Contract Manufacturing
- Hard Capsules Manufacturing
- Soft Capsules Manufacturing
- Tablets Manufacturing
- Sticks & Sachets Manufacturing
- Oil Mixtures Manufacturing
- Coating / Filming Services
- Powder Manufacturing
- Ready-to-Market Private Label Products
- Epax Omega-3 Marine Concentrates
- Algae Oil Vegan Omega-3 Products
- Probiotic Manufacturing Solutions
- Contract Packaging Services
Quantifiable outcome
- Products are certified according to ISO 9001:2015, 22000:2018, BIO (DE-ÖKO 005 VO (EG) 834/2007), Friend of the Sea (FOS), and Marine Stewardship Council (MSC)
Companies that use Goerlich Pharma
Customer profileSegments2 records
Ideal customer profiles2 records
Goerlich Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Goerlich Pharma partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- Epax Norway AScoreExclusive partnership for Epax® Omega-3 premium concentrates in Germany, Austria, and Switzerland. Epax is a world-leading Norwegian Omega-3 premium brand offering highly concentrated marine omega-3 preparations with defined EPA/DHA ratios. Products include EPAX 1050 TG, EPAX 4020 TG, and TGN concentrates. Available in 190 kg drums.
- Friend of the Sea (FOS)minorSustainability certification program for sustainable and environmentally friendly fisheries. Goerlich Pharma products with FOS certification ensure sustainable sourcing of marine omega-3 ingredients.
- Marine Stewardship Council (MSC)minorGlobal sustainability certification for responsible fisheries. Goerlich Pharma holds MSC certification for marine ingredient sourcing.
- Innsiders Media GmbHminorWebsite hosting and development partner. Located at Spinnereiinsel 3B, 83059 Kolbermoor, Germany. Provides website hosting services with data processing agreement in place.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
Goerlich Pharma competitors and assessment
Company assessmentBroad incumbents
- Recipharm: Recipharm is a large European pharmaceutical CDMO offering solid dose, semi-solid, and sterile manufacturing. It is a broader incumbent that overlaps with Goerlich in supplement and OTC contract manufacturing while serving a wider portfolio across the pharmaceutical value chain.
- Catalent (Novo Holdings): Catalent is a global CDMO with extensive capabilities in softgel, oral solid, and biopharmaceutical manufacturing. It is a broad incumbent that overlaps with Goerlich on softgel capsules and other galenic formats, typically serving larger multinational supplement and pharma customers.
- Eurofins CDMO: Eurofins CDMO is the contract manufacturing arm of Eurofins Scientific, offering drug substance and drug product development across Europe. It is a broad incumbent that competes with Goerlich for B2B contract projects in the supplement-adjacent OTC and nutraceutical space.
Direct peers
- Aenova Group: Aenova is one of Europe's largest pharmaceutical and dietary supplement contract manufacturers, headquartered in Germany. It directly competes with Goerlich across solid, semi-solid, and liquid dosage forms for B2B supplement brands, and serves as the most direct German CMOs comparable in scale and customer base.
- Bioplus Life Sciences (Arnet Pharmaceutical): Bioplus is an India-based contract manufacturer of dietary supplements in capsules, tablets, sachets, and powders. It is a direct peer in private-label and custom supplement manufacturing, serving global B2B health and nutrition brands similar to Goerlich's customer base.
- Finzelberg (Martin Bauer Group): Finzelberg is a German contract manufacturer specializing in plant-based extracts and botanical supplement formulations. It is a direct peer in botanical and natural supplement contract manufacturing with comparable private-label and B2B service models serving health brands across Europe.
- Sirio Pharma: Sirio Pharma is a global CDMO specializing in nutritional supplements, gummies, softgels, and probiotics. It directly competes with Goerlich in contract manufacturing of branded and private-label supplements, including probiotics and omega-3 formats.
- Losan Pharma: Losan Pharma is a German pharmaceutical contract developer and manufacturer offering solid, semi-solid, and liquid dosage forms. It is a direct competitor to Goerlich in the German supplement and OTC CDMO market, serving similar B2B brand customers with comparable galenic capabilities.
Regional players
- Nordmark Pharma: Nordmark Pharma is a German contract manufacturer of biologicals, pharmaceuticals, and supplements based in Northern Germany. It is a regional peer offering similar B2B contract services to Goerlich, with particular strength in biological and natural-source formulations.
- Hermes Arzneimittel: Hermes Arzneimittel is a German pharmaceutical manufacturer with CDMO and contract manufacturing capabilities. It is a regional player comparable to Goerlich in serving German and European B2B customers with solid and liquid dosage forms, though its portfolio is broader on the pharma side.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Goerlich Pharma compliance and trust
Trust signalCompliance7 records
Goerlich Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Goerlich Pharma leadership team
Management profileNumber of profiles
Profiles6 records
Goerlich Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Goerlich Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Goerlich Pharma
What does Goerlich Pharma do?
Goerlich Pharma is a German B2B contract manufacturer and packager of food supplements and foods for medical purposes, offering full-service support from product idea to market-ready delivery. The company produces seven galenic dosage forms (hard capsules, soft capsules, tablets, sticks & sachets, oil mixtures, coating/filming, and powder) and supplies both custom private label and ready-to-market formulations across health categories including omega-3, probiotics, eye health, cardiovascular, immune system, women's health, beauty, longevity, and sport & fitness.
Is Goerlich Pharma a public or private company?
Goerlich Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Goerlich Pharma founded?
Goerlich Pharma was founded in 1984. It employs 51 to 100 people.
Where is Goerlich Pharma based?
Goerlich Pharma is headquartered in Nolle, Germany, in the Europe region.
How does Goerlich Pharma make money?
Three revenue lines are on record. Contract Manufacturing Services are the primary driver. The others are private Label Products and ready-to-Market Products.
Who are Goerlich Pharma's main competitors?
Broad incumbents on record are Recipharm, Catalent (Novo Holdings) and Eurofins CDMO. Direct peers are Aenova Group, Bioplus Life Sciences (Arnet Pharmaceutical), Finzelberg (Martin Bauer Group), Sirio Pharma and Losan Pharma. Regional players are Nordmark Pharma and Hermes Arzneimittel.
Does Goerlich Pharma have an API?
No public API is recorded for Goerlich Pharma.
What industry is Goerlich Pharma in?
Goerlich Pharma's product category is Contract Manufacturing - Dietary Supplements. Its primary akta.pro industry code is CRADAGAI, Functional Foods & Supplement Formats (Gummies, Chews, Powders, Shots), with a secondary code of CRADAGAF, Probiotics & Digestive Health Supplements. Its NAICS code is 325412 and its SIC code is 2000.